Zhang Liang, Wang Hailong, Liang Gaofeng, Chen Tian, Ge Ting
Department of Respiratory Medicine, The Affiliated LiHuiLi Hospital of Ningbo University, 57 Xingning Road, Yinzhou District, Ningbo City, 315000, Zhejiang Province, China.
Department of Thoracic Surgery, The Affiliated LiHuiLi Hospital of Ningbo University, 57 Xingning Road, Yinzhou District, Ningbo City, 315000, Zhejiang Province, China.
J Mol Histol. 2025 Aug 6;56(4):255. doi: 10.1007/s10735-025-10502-7.
Ferroptosis, a newly identified form of regulated cell death, has emerged as a promising therapeutic target in cancer treatment. The study was to clarify the regulatory effects of Yin Yang 1 (YY1) on ATP Binding Cassette Subfamily B Member 7 (ABCB7) expression and its related functions in lung adenocarcinoma (LUAD), focusing on ferroptosis.
The bioinformatics analysis of ABCB7 expression in LUAD was initially conducted using public databases and subsequently validated through the examination of LUAD tissue samples. The effects of ABCB7 knockdown and YY1 overexpression on LUAD cell proliferation, migration, invasion, and sensitivity to ferroptosis were evaluated using a series of in vitro assays.
Elevated expression of ABCB7 in lung adenocarcinoma (LUAD) was significantly associated with poorer patient survival rates. Silencing of ABCB7 led to a marked reduction in LUAD cell proliferation, migration, and invasion, while concurrently inducing ferroptosis. Moreover, overexpression of YY1 was found to partially reverse these biological effects. Mechanistic investigations revealed that YY1 targets and activates the ABCB7 promoter, a conclusion supported by dual-luciferase assays. In vivo studies further confirmed that knockdown of ABCB7 inhibited LUAD cell proliferation and increased susceptibility to ferroptosis.
Our research suggests that YY1-mediated activation of ABCB7 may contribute to LUAD progression and potentially influences ferroptosis susceptibility. Targeting the YY1-ABCB7 axis emerges as a potential novel therapeutic approach for LUAD management.
铁死亡是一种新发现的程序性细胞死亡形式,已成为癌症治疗中一个有前景的治疗靶点。本研究旨在阐明阴阳1(YY1)对肺腺癌(LUAD)中ATP结合盒亚家族B成员7(ABCB7)表达的调控作用及其相关功能,重点关注铁死亡。
首先利用公共数据库对LUAD中ABCB7的表达进行生物信息学分析,随后通过检测LUAD组织样本进行验证。使用一系列体外实验评估ABCB7敲低和YY1过表达对LUAD细胞增殖、迁移、侵袭及铁死亡敏感性的影响。
肺腺癌(LUAD)中ABCB7表达升高与患者较差的生存率显著相关。ABCB7沉默导致LUAD细胞增殖、迁移和侵袭显著减少,同时诱导铁死亡。此外,发现YY1过表达可部分逆转这些生物学效应。机制研究表明,YY1靶向并激活ABCB7启动子,双荧光素酶实验支持这一结论。体内研究进一步证实,ABCB7敲低可抑制LUAD细胞增殖并增加对铁死亡的敏感性。
我们的研究表明,YY1介导的ABCB7激活可能促进LUAD进展,并可能影响铁死亡易感性。靶向YY1-ABCB7轴成为LUAD治疗的一种潜在新方法。